What is the HDL cholesterol cut point recommended by NCEP?
The NCEP has recommended that HDL cholesterol levels be measured at the time of cholesterol testing. An HDL cholesterol level of <35 mg/dL is listed as a major and independent risk factor for CHD.
What are the optimum guidelines for HDL and LDL counts?
Men age 20 or older:
| Type of Cholesterol | Healthy Level |
|---|---|
| Total Cholesterol | 125 to 200mg/dL |
| Non-HDL | Less than 130mg/dL |
| LDL | Less than 100mg/dL |
| HDL | 40mg/dL or higher |
What is the normal range for HDL ratio?
Normal: 45 to 70 mg/dL for men, 50 to 90 mg/dL for women.
What are the ATP III guidelines?
As shown in Table 2, an LDL cholesterol level of <100 mg/dL is optimal; therefore, ATP III specifies an LDL cholesterol <100 mg/dL as the goal of therapy in secondary prevention. This goal is supported by clinical trials with both clinical and angiographic endpoints and by prospective epidemiological studies.
What is the lipid testing protocol for adults recommended by the NCEP to evaluate risk for atherosclerosis beginning at age 20?
In addition to the USPSTF guidelines, lipid disorder screening recommendations also have been published by the National Cholesterol Education Program (NCEP) (5), which recommends a complete fasting lipoprotein profile (TC, LDL-C, and TG) for all adults aged ≥20 years as the preferred screening test.
What are the most recent cholesterol guidelines?
As far as LDL-cholesterol targets, ISH guidelines states, that it should be reduced according to risk profile: (1) >50% and <70 mg/dL (1.8 mmol/L) in hypertension with cardiovascular disease (CVD), chronic kidney disease (CKD), diabetes mellitus (DM) or no CVD and high risk; (2) >50% and <100 mg/dL (2.6 mmol/L) in high …
What does NCEP ATP III stand for?
Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III) presents the National Cholesterol Education Program (NCEP) updated recommendations on cholesterol testing and management.
What are the NCEP II guidelines on pharmacological therapy for LDL-C levels?
Under the guidelines contained in the Second Report of the NCEP (NCEP II), patients exhibiting an LDL-C level ≥190 mg/dL and who have ≤1 additional risk factor are considered eligible for pharmacological therapy after lifestyle recommendations have failed to alter lipid levels.
What do the new ATP III cholesterol guidelines mean for You?
The NCEP has predicted that the new ATP III guidelines will increase the number of Americans requiring treatment for elevated cholesterol levels (from 52 million to 65 million) and nearly triple the number of Americans who will need to take cholesterol lowering drugs (from 13 million to 36 million Americans).
What is the LDL cholesterol goal for multiple risk factors (2+)?
The LDL cholesterol goal for persons with multiple (2+) risk factors is <130 mg/dL. The third category consists of persons having 0-1 risk factor; with few exceptions, persons in this category have a 10-year risk <10%. Their LDL cholesterol goal is <160 mg/dL.
How many patients with LDL-C >160 are eligible for optional drug treatment?
Overall, 71% of treatment-eligible patients exhibited LDL-C ≥160 mg/dL, which alone qualifies them for optional drug treatment if liberal criteria are applied. Proportionally more females (79%) than males (64%) qualify for therapy under this scenario. Table 7101971. Frequency and Percentage of NCEP III–Eligible Patients Exhibiting LDL-C ≥160 mg/dL